Topics

Articles

List includes 21 new orphan drugs, and of the 45, 15 are cold chain products

Are hubs a help or hindrance in getting patients on therapy?

Even with legislative incentives, pharma manufacturers struggle to cost-justify pediatric innovation

Biennial survey finds growing awareness of information options by consumers

Xerox subsidiary expands its call-center operations to include specialty reimbursement services

Survey shows that most digital channels are still experiments with little oversight or follow-through

With competing products and pricing pressure, the rare disease market is starting to resemble the conventional drug market

Latest SK&A pharmacy data outlines retail channel

While the biopharma industry continues to develop better treatment options, there is a stronger focus on more intensive patient engagement